Tadalafil and fluoxetine in premature ejaculation: Prospective, randomized, double-blind, placebo-controlled study

Urologia Internationalis

Volumn 80, Issue 2, 2008, Pages 162-165

  Mattos, Rogerio M ^a,b   Marmo Lucon, Antonio ^a   Srougi, Miguel ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Ejaculation; Fluoxetine; Phosphodiesterase inhibitors; Sexual dysfunctions

Indexed keywords

FLUOXETINE; PLACEBO; TADALAFIL;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; ASTHENIA; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EJACULATION; ERECTILE DYSFUNCTION; FACE ERYTHEMA; FOLLOW UP; HEADACHE; HEART PALPITATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MYALGIA; NAUSEA; PREMATURE EJACULATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEXUAL INTERCOURSE; SIDE EFFECT; SOMNOLENCE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; YAWNING;

ADULT; CARBOLINES; DOUBLE-BLIND METHOD; EJACULATION; FLUOXETINE; HUMANS; MALE; MIDDLE AGED; PHOSPHODIESTERASE INHIBITORS; PROSPECTIVE STUDIES; SEROTONIN UPTAKE INHIBITORS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; TIME FACTORS;

EID: 41149130086     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000112607     Document Type: Article

References (19)

1. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV, ed 4, text revision. Washington, American Psychiatric Association, 2000.
2. Godpodinoff ML: Premature ejaculation: clinical subgroups and etiology. J Sex Marital Ther 1989;15:130-134.
3. Balon R: Antidepressants in the treatment of premature ejaculation. J Sex Marital Ther 1996;22:85-96.
4. Salonia A, Maga T, Colombo R, Scattoni V, Briganti A, Cestari A, Guazzoni G, Rigatti P, Montorsi F: A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation. J Urol 2002;168:2486-2489.
5. Kim SC, SEO KK: Efficacy and safety of fluoxetine, sertraline and clomipramine in patients with premature ejaculation: a double-blind, placebo controlled study. J Urol 1998;159:425-427.
6. Pryor J, Althof SE, Steidle C, Rosen RC, Hellstrom WJG, Shabsigh R, Miloslavsky M, Kell S: Efficacy and tolerability of dapoxetine in the treatment of premature ejaculation: an integrated analysis of two double-blind, randomized controlled trials. Lancet 2006;368: 929-937.
7. Dresser MJ, Desai D, Gidwani S, Seftel AD, Modi NB: Dapoxetine, a novel treatment for premature ejaculation, does not have pharmacokinetic interactions with phosphodiesterase-5 inhibitors. Int J Impot Res 2006;18: 104-110.
8. Aversa A, Mazzilli F, Rossi T, Delfino M, Isidori AM, Fabbri A: Effects of sildenafil administration on seminal parameters and post-ejaculatory time in normal males. Hum Reprod 2000;15:131-134.
9. Mondaini N, Ponchietti R, Muir GH, Montorsi F, Di Loro F, Lombardi G, Rizzo M: Sildenafil does not improve sexual function but does reduce the postorgasmic refractory time. Int J Impot Res 2003;15:225-228.
10. Abdel-Hamid IA: Phosphodiesterase 5 inhibitors in rapid ejaculation: potential use and possible mechanisms of action. Drugs 2004;64:13-26.
11. Chen J, Mabjeesh NJ, Matzkin H, Greenstein A: Efficacy of sildenafil as adjuvant therapy to selective serotonin reuptake inhibitor in alleviating premature ejaculation. Urology 2003;61:197-200.
12. McMahon CG, Bronwyn GA, Stuckey BA, Andersen M, Purvis K, Koppiker N, Haughie S, Boolell M: Efficacy of sildenafil citrate (Viagra) in men with premature ejaculation. J Sex Med 2005;2:368-375.
13. Althof SE: Prevalence, characteristics and implications of premature ejaculation/rapid ejaculation. J Urol 2006;175:842-848.
14. Manasia P, Pomerol J, RibéN, Pozo RG, Garcia JA: Comparison of the efficacy and safety of 90 mg versus 20 mg fluoxetine in the treatment of premature ejaculation. J Urol 2003;170:164-165.
15. Wagstaaf AJ, e Goa KL: Once-Weekly Fluoxetine. Drugs 2001;15:2221-2228.
16. Schmidt ME, Fava M, Robinson JM: The efficacy and safety of a new enteric-coated formulation of fluoxetine given once weekly during the continuation treatment of major depressive disorder. J Clin Psychiatry 2000;11:851-857.
17. Schmidt ME, Gonzales J, Michelson D: Sexual functioning during acute and continuation therapy with fluoxetine: a prospective assessment. Psychosomatics 2001;2:196.
18. Sotomayor M: The burden of premature ejaculation: the patient's perspective. J Sex Med 2005;2:110-114.
19. McMahon CG, McMahon CN, Leow LJ, Winestock CG: Efficacy of type-5 phosphodiesterase inhibitors in the drug treatment of premature ejaculation: a systematic review. BJU Int 2006;98:259-272.